The HeartMate II™ Left Ventricular Assist Device (LVAD) provides short or long-term circulatory support for intermediate-to-advanced heart failure patients. This small, quiet pump features a simple design — with only one moving part — and can provide blood flow equivalent to that of a healthy heart.
The HeartMate II LVAD is indicated for both destination therapy and bridge-to-transplantation in the United States. Additionally, HeartMate II LVAD is backed by more than 10 years of clinical experience.2
To date, more than 27,000 heart failure patients have received the HeartMate II LVAD.1 Many have passed the 5-year milestone on therapy, with some still on therapy after 10-plus years.1 These figures offer more than a decade of living proof that HeartMate II LVAD delivers predictable surgical and clinical performance for improved outcomes.3-8
Research has shown the HeartMate II LVAD:
At baseline, patients who were tested completed the 6-minute walk test at an average of 129 meters. At 2 years after HeartMate II LVAD implant, patients completed the test at an average of 361 meters. That's two and a half times as far, for a 150% improvement in distance.8
PREVENT Guidelines are a set of clinical and surgical recommendations that are aimed at maximizing flow through the LVAD, reducing risk of cannula malposition, and ensuring that the patients are adequately anti-coagulated while on LVAD support.
The HeartMate II LVAD is designed for patient comfort and convenience. With its wearable design and several carrying options, the HeartMate II LVAD supports your patients’ lifestyles. Other features and benefits:
The HeartMate II LVAD comes with a lightweight, pocket-sized controller that interfaces with the implanted pump. Its features are designed for safety:
*Please reference the HeartMate II LVAS Instructions for Use for additional information.
MAT-2010996 v1.0
